FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 11th, 2009 • Xoma LTD /De/ • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (“Agreement”), effective as of this 30th day of December, 2008, by and between XOMA (US) LLC (“XOMA” or the “Company”), a Delaware limited liability company with its principal office at 2910 Seventh Street, Berkeley, California, and (“Employee”), an individual residing at .
FORM OF XOMA LTD. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • March 11th, 2009 • Xoma LTD /De/ • Pharmaceutical preparations • California
This Amended and Restated Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of , 200_ (the “Effective Date”), by and between (the “Employee”) and XOMA Ltd., a Bermuda company (the “Company”).
AMENDED AND RESTATED RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTResearch, Development and Commercialization Agreement • March 11th, 2009 • Xoma LTD /De/ • Pharmaceutical preparations
This Amended and Restated Research, Development and Collaboration Agreement (this “Agreement”) is effective as of July 1, 2008 (the “Effective Date”) by and between Novartis Vaccines and Diagnostics, Inc. (f/k/a Chiron Corporation), a Delaware corporation with offices at 4650 Horton Street, Emeryville, California 94608 (together with its Affiliates, “NVDI”), and XOMA (US) LLC, a Delaware limited liability company with offices at 2910 Seventh Street, Berkeley, California 94710 (together with its Affiliates, “XOMA”). NVDI and XOMA are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” When used in this Agreement, capitalized terms shall have the meanings set forth in Article 1.
MANUFACTURING AND TECHNOLOGY TRANSFER AGREEMENTManufacturing and Technology Transfer Agreement • March 11th, 2009 • Xoma LTD /De/ • Pharmaceutical preparations • California
This Manufacturing and Technology Transfer Agreement (this “Agreement”) is effective as of July 1, 2008 (the “Effective Date”), by and between XOMA (US) LLC, a Delaware limited liability company with offices at 2910 Seventh Street, Berkeley, California 94710 (“XOMA”), and Novartis Vaccines and Diagnostics, Inc., a Delaware corporation with offices at 4650 Horton Street, Emeryville, California 94608 (“NVDI”). XOMA and NVDI are sometimes referred to herein individually as a “Party” and collectively as “Parties.”
